Research Participant COVID-19 Risk Information Documents

For studies where a Tier 1 petition to continue in-person activities/new enrollment was approved after 4/3/2020 and research studies approved to restart, researchers must provide each participant being seen with the below IRB-approved COVID-19 Risk Information Sheet using the following procedures:

1. Research teams must attempt to contact each participant before their scheduled research visit to provide this information about COVID-19 risks.
2. When participants arrive for a research-related visit, the study team must confirm that the participant has received this information. If not, then this information must be provided at that time.

For all research studies that will pause in-person activities, investigators must incorporate the COVID-19 Study Pause Guidelines into their communication with research participants.

• COVID-19 Research Participant Risk Information Sheet - Revised version posted 2/4/2021
• Spanish Translation of COVID-19